Credit Suisse’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | $265M | Sell |
|
|||||
2023
Q4 | $343M | Buy |
|
|||||
2023
Q3 | $358M | Buy |
|
|||||
2023
Q2 | $373M | Buy |
|
|||||
2023
Q1 | $386M | Buy |
|
|||||
2022
Q4 | $389M | Buy |
|
|||||
2022
Q3 | $343M | Buy |
|
|||||
2022
Q2 | $361M | Buy |
|
|||||
2022
Q1 | $314M | Buy |
|
|||||
2021
Q4 | $254M | Sell |
|
|||||
2021
Q3 | $243M | Sell |
|
|||||
2021
Q2 | $289M | Sell |
|
|||||
2021
Q1 | $290M | Sell |
|
|||||
2020
Q4 | $299M | Sell |
|
|||||
2020
Q3 | $318M | Buy |
|
|||||
2020
Q2 | $295M | Sell |
|
|||||
2020
Q1 | $355M | Sell |
|
|||||
2019
Q4 | $692M | Buy |
|
|||||
2019
Q3 | $533M | Sell |
|
|||||
2019
Q2 | $539M | Buy |
|
|||||
2019
Q1 | $172M | Sell |
|
|||||
2018
Q4 | $359M | Buy |
|
|||||
2018
Q3 | $195M | Sell |
|
|||||
2018
Q2 | $177M | Buy |
|
|||||
2018
Q1 | $199M | Sell |
|
|||||
2017
Q4 | $243M | Buy |
|
|||||
2017
Q3 | $248M | Sell |
|
|||||
2017
Q2 | $225M | Sell |
|
|||||
2017
Q1 | $343M | Buy |
|
|||||
2016
Q4 | $355M | Buy |
|
|||||
2016
Q3 | $192M | Buy |
|
|||||
2016
Q2 | $217M | Buy |
|
|||||
2016
Q1 | $183M | Sell |
|
|||||
2015
Q4 | $210M | Sell |
|
|||||
2015
Q3 | $217M | Sell |
|
|||||
2015
Q2 | $477M | Buy |
|
|||||
2015
Q1 | $371M | Buy |
|
|||||
2014
Q4 | $262M | Buy |
|
|||||
2014
Q3 | $194M | Buy |
|
|||||
2014
Q2 | $174M | Sell |
|
|||||
2014
Q1 | $204M | Buy |
|
|||||
2013
Q4 | $189M | Sell |
|
|||||
2013
Q3 | $186M | Sell |
|
|||||
2013
Q2 | $226M | Buy |
|